Shanghai GenTech (688596) Fundamentals 2026 — P/E 175.3x, Revenue Analysis | SniperIQ
Shanghai GenTech (688596) is a CN-listed Industrials company in Industrial - Machinery with a market capitalization of ¥13.7B, trading at ¥47.41 on the SHH. This SniperIQ fundamentals page covers Shanghai GenTech's valuation (P/E 175.3x, P/B 3.6x), profitability (net margin 1.5%), revenue (¥4.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shanghai GenTech's market cap?
Shanghai GenTech (688596) has a market capitalization of approximately ¥13.7B, trading at ¥47.41 on the SHH. Market cap moves with the live share price.
What is Shanghai GenTech's P/E ratio?
Shanghai GenTech's trailing twelve-month P/E ratio is 175.3x, with a price-to-book (P/B) of 3.6x. Valuation multiples are best compared with Industrials sector peers rather than read in isolation.
How profitable is Shanghai GenTech?
Shanghai GenTech runs a net profit margin of 1.5%, a gross margin of 1.9%, and an operating margin of 1.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shanghai GenTech generate?
Shanghai GenTech reported revenue of ¥4.9B for fiscal year 2025, with net income of ¥136M and earnings per share (EPS) of 0.47. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shanghai GenTech pay a dividend?
Shanghai GenTech offers a trailing dividend yield of about 0.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shanghai GenTech financially healthy?
Shanghai GenTech carries a debt-to-equity ratio of 1.01x and a current ratio of 1.38x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shanghai GenTech a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shanghai GenTech (688596) the key facts are: market cap ¥13.7B, P/E 175.3x, revenue ¥4.9B, 52-week range 27.51-88.66. Weigh valuation, profitability, growth, and balance-sheet strength against Industrials peers and form your own view.
Track Shanghai GenTech's full fundamentals live
Get Shanghai GenTech's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.